MRNA — Moderna, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1682852 ·
Last close
$198.88
Market Cap
$79.40B
52W High
$202.67
52W Low
$22.28
ADV30
28,168,573
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — — — —
Mar 2026 389,000,000 -566,000,000 -1,388,000,000 -1,343,000,000 11,488,000,000 1,908,000,000 4,080,000,000
Dec 2025 676,000,000 224,000,000 -857,000,000 -826,000,000 12,338,000,000 2,595,000,000 3,688,000,000
Sep 2025 1,002,000,000 795,000,000 -260,000,000 -200,000,000 12,135,000,000 1,132,000,000 2,805,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,466,000,000
Investing CF
$1,140,000,000
Financing CF
$606,000,000
CapEx
$-137,000,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-7.99
As of
2026-08-02

Balance + Analyst (yfinance extras)

Retained Earnings
$5,880,000,000
Inventory
$146,000,000
Receivables
$182,000,000
ST Investments
$3,297,000,000
EBIT TTM
$-3,112,000,000
Pretax Income TTM
$-3,138,000,000
Interest Exp TTM
$26,000,000
Analysts
19

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,228,000,000
EBITDA
$-2,195,000,064
Free Cash Flow
$299,249,984
Enterprise Value
$53,626,990,592
Total Cash
$5,137,999,872
Total Debt
$1,287,000,064
Shares Out
399,235,889
Trailing EPS
$-7.98
Book Value
$16.95
ROE
-39.0%
ROA
-13.3%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,922,000,000 -3,074,000,000 -2,822,000,000 12,338,000,000 3,688,000,000 8,650,000,000 -1,873,000,000
Dec 2024 3,199,000,000 -3,945,000,000 -3,561,000,000 14,142,000,000 3,241,000,000 10,901,000,000 -3,004,000,000
Dec 2023 6,754,000,000 -4,239,000,000 -4,714,000,000 18,426,000,000 4,572,000,000 13,854,000,000 -3,118,000,000
Dec 2022 18,875,000,000 9,420,000,000 8,362,000,000 25,858,000,000 6,735,000,000 19,123,000,000 4,981,000,000

TTM Snapshot

Revenues TTM
$7,165,000,000
NetIncome TTM
$-3,545,000,000
OpCashFlow TTM
$0
Assets (Latest)
$12,338,000,000
Forward EPS
$-4.47

Max Pain — expiry 2026-10-02

max pain strike: $195.00 · spot: $198.88 · call oi: 3,543 · put oi: 23,264
Expected Move to 2026-10-02: ±$17.25 (8.67%) — implied range $181.63 – $216.13 · ATM straddle on $200.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ARGX ARGENX SE $59.67B $959.49 —
RVMD Revolution Medicines, Inc. $43.93B $204.97 —
GILD GILEAD SCIENCES, INC. $187.15B $150.93 —
BIIB BIOGEN INC. $33.63B $227.60 —
AMGN AMGEN INC $224.15B $414.61 —

News headlines (Yahoo Finance, 1h cache)

MRNA Stock Eyes Best Year Ever: Analyst Calls China’s AI Drug Lead ‘Baseless’ As Moderna Awaits Cancer Data
2026-09-28 07:59 · Yahoo
Why Did AMD, HPE, MRNA Stocks Surge To 52-Week Highs Last Week?
2026-09-28 04:47 · Yahoo
Why Moderna (MRNA) Is Up 29.1% After Melanoma Vaccine Success And Middle East Expansion Talks
2026-09-27 01:11 · Yahoo
Moderna (MRNA) Held Investment Talks With The UAE Government
2026-09-27 00:11 · Yahoo
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
2026-09-25 20:50 · Yahoo
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today?
2026-09-25 18:37 · Yahoo
Moderna Stock Jumped 7% Thursday. The Real Test Comes at ESMO on October 24.
2026-09-25 05:07 · Yahoo
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
2026-09-25 03:23 · Yahoo
Moderna Inc. (MRNA) Holds High-Level Investment Talks With UAE, Soars to 4-Year Peak
2026-09-25 00:46 · Yahoo
From $63 To $195: Moderna’s Two-Month Rerating Isn’t Done
2026-09-24 22:41 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.